YY1 and acute myeloid leukemia: Next, we treated cells from a YY1 high-expressing AML sample (Figure 1B) with 2.5 nM Bortezomib and analyzed YY1 mRNA and protein levels over 72 h at 24 h intervals (Figure 1C).